Group items tagged

"The global alopecia market size is anticipated to reach USD 4.8 billion by 2026, registering an 8.3% CAGR during the forecast period. The market is expected to be driven by increase in disease prevalence, technological advancements, and rise in per-capita healthcare expenditures across the globe. The disease prevalence is increasing due to changing lifestyle patterns, such as increased consumption of alcohol and tobacco, changing food habits, high level of stress, and rising geriatric population. These factors are expected to boost the market over the forecast period. In addition, rising incidences of chronic diseases such as Polycystic Ovary Syndrome (PCOS), cancer, and rheumatoid arthritis are likely to fuel market growth."

With its six-month post injection follow-up period for its key clinical trial nearing completion, RepliCel provides an update on its innovative hair loss treatment.

Leading hair biology scientist Rolf Hoffmann discusses in cell-based hair loss treatments and the critical steps RepliCel Life Sciences is taking to ensure that it is successful.